Early-Phase Adverse Effects and Management of Liposomal Amikacin Inhalation for Refractory Mycobacterium avium Complex Lung Disease in Real-World Settings

Atsuho Morita,1 Ho Namkoong,2 Kazuma Yagi,1 Takanori Asakura,1 Makoto Hosoya,3 Hiromu Tanaka,1 Ho Lee,1 Takunori Ogawa,1 Tatsuya Kusumoto,1 Shuhei Azekawa,1 Kensuke Nakagawara,1 Hirofumi Kamata,1 Makoto Ishii,1 Koichi Fukunaga,1 Hiroyuki Ozawa,3 Naoki Hasegawa2 1Division of Pulmonary Medicine, Depar...

詳細記述

書誌詳細

出版年:	Infection and Drug Resistance
主要な著者:	Morita A, Namkoong H, Yagi K, Asakura T, Hosoya M, Tanaka H, Lee H, Ogawa T, Kusumoto T, Azekawa S, Nakagawara K, Kamata H, Ishii M, Fukunaga K, Ozawa H, Hasegawa N
フォーマット:	論文
言語:	英語
出版事項:	Dove Medical Press 2022-07-01
主題:	mycobacterium avium complex mac nontuberculous mycobacteria ntm amikacin liposome inhalation suspension alis
オンライン･アクセス:	https://www.dovepress.com/early-phase-adverse-effects-and-management-of-liposomal-amikacin-inhal-peer-reviewed-fulltext-article-IDR